133 related articles for article (PubMed ID: 37263740)
1. The longitudinal influence of ADHD status and stimulant medication on body mass index and blood pressure among youth with obesity.
Kollin SR; Lim CS; Lee AA
Pediatr Obes; 2023 Sep; 18(9):e13058. PubMed ID: 37263740
[TBL] [Abstract][Full Text] [Related]
2. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004.
Byrd HC; Curtin C; Anderson SE
Pediatr Obes; 2013 Dec; 8(6):445-53. PubMed ID: 23325553
[TBL] [Abstract][Full Text] [Related]
3. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
[TBL] [Abstract][Full Text] [Related]
4. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
Rose SR; Reeves G; Gut R; Germak J
J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822
[TBL] [Abstract][Full Text] [Related]
5. Co-occurring weight problems among children with attention deficit/hyperactivity disorder: the role of executive functioning.
Graziano PA; Bagner DM; Waxmonsky JG; Reid A; McNamara JP; Geffken GR
Int J Obes (Lond); 2012 Apr; 36(4):567-72. PubMed ID: 22158266
[TBL] [Abstract][Full Text] [Related]
6. What is the effect of ADHD stimulant medication on heart rate and blood pressure in a community sample of children?
St Amour MD; O'Leary DD; Cairney J; Wade TJ
Can J Public Health; 2018 Jun; 109(3):395-400. PubMed ID: 29981090
[TBL] [Abstract][Full Text] [Related]
7. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
McCabe SE; Dickinson K; West BT; Wilens TE
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Stimulant Medications on Blood Pressure and Body Mass Index in Children with Attention Deficit Hyperactivity Disorder.
Suess M; Chrenka EA; Kharbanda EO; Asche S; O'Connor PJ; Ekstrom H; Benziger CP
Acad Pediatr; 2024 Apr; 24(3):424-432. PubMed ID: 37652161
[TBL] [Abstract][Full Text] [Related]
9. Half of the children with overweight or obesity and attention-deficit/hyperactivity disorder reach normal weight with stimulants.
Fast K; Björk A; Strandberg M; Johannesson E; Wentz E; Dahlgren J
Acta Paediatr; 2021 Oct; 110(10):2825-2832. PubMed ID: 33876865
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
[TBL] [Abstract][Full Text] [Related]
11. Attention-Deficit/Hyperactivity Disorder is Related to Decreased Weight in the Preschool Period and to Increased Rate of Overweight in School-Age Boys.
Hanć T; Słopień A; Wolańczyk T; Szwed A; Czapla Z; Durda M; Dmitrzak-Węglarz M; Ratajczak J
J Child Adolesc Psychopharmacol; 2015 Nov; 25(9):691-700. PubMed ID: 26401547
[TBL] [Abstract][Full Text] [Related]
12. Attention deficit hyperactivity disorder medications and BMI trajectories: The role of medication type, sex and age.
Gurka MJ; Siddiqi SU; Filipp SL; Mercado R; Thompson LA; Janicke DM; Shenkman EA
Pediatr Obes; 2021 Apr; 16(4):e12738. PubMed ID: 33064373
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder.
Cartabuke RS; Tobias JD; Rice J; Tumin D
Paediatr Anaesth; 2017 Apr; 27(4):417-424. PubMed ID: 28181385
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Correlates of Attention-Deficit Hyperactivity Disorder in a Diverse, Treatment-Seeking Pediatric Overweight/Obesity Sample.
Merrill BM; Morrow AS; Sarver D; Sandridge S; Lim CS
J Dev Behav Pediatr; 2021 Aug; 42(6):433-441. PubMed ID: 34397571
[TBL] [Abstract][Full Text] [Related]
15. Examining the relationship between attention-deficit/hyperactivity disorder and overweight in children and adolescents.
Erhart M; Herpertz-Dahlmann B; Wille N; Sawitzky-Rose B; Hölling H; Ravens-Sieberer U
Eur Child Adolesc Psychiatry; 2012 Jan; 21(1):39-49. PubMed ID: 22120761
[TBL] [Abstract][Full Text] [Related]
16. ADHD Medication, Dietary Patterns, Physical Activity, and BMI in Children: A Longitudinal Analysis of the ECLS-K Study.
Bowling A; Davison K; Haneuse S; Beardslee W; Miller DP
Obesity (Silver Spring); 2017 Oct; 25(10):1802-1808. PubMed ID: 28834373
[TBL] [Abstract][Full Text] [Related]
17. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
[TBL] [Abstract][Full Text] [Related]
18. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
Blader JC; Pliszka SR; Kafantaris V; Foley CA; Crowell JA; Carlson GA; Sauder CL; Margulies DM; Sinha C; Sverd J; Matthews TL; Bailey BY; Daviss WB
J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1281-93. PubMed ID: 24290461
[TBL] [Abstract][Full Text] [Related]
19. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
[TBL] [Abstract][Full Text] [Related]
20. Body Mass Indices of Girls with and without ADHD: Developmental Trajectories from Childhood to Adulthood.
Porter PA; Henry LN; Halkett A; Hinshaw SP
J Clin Child Adolesc Psychol; 2022; 51(5):688-700. PubMed ID: 33625277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
